Trials / Conditions / Gastrointestinal Motility Disorder

Gastrointestinal Motility Disorder

17 registered clinical trials studyying Gastrointestinal Motility Disorder — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	"The Effect of Abdominal Massage on Gastrointestinal Functions in Mechanically Ventilated Patients Receiving E NCT06631001	Mersin University	N/A
Recruiting	Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis NCT05989763	The University of Texas Health Science Center, Houston	N/A
Active Not Recruiting	Short-term Effect of Exercise and Self-manual Approaches to Bloating - Distention NCT06347367	Ege University	N/A
Unknown	The Effect of Foot Reflexology After Cesarean Section NCT05268328	Nülüfer Erbil	—
Withdrawn	Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility NCT04244877	MetroHealth Medical Center	Phase 3
Unknown	Gastrointestinal Motor Disorders (Esophageal and Anorectal) After COVID-19 NCT04988438	University Hospital Dubrava	—
Recruiting	IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy NCT04208828	University of Louisville	—
Unknown	Intestinal Dysmotility in Patients With Functional Digestive Symptoms NCT04764019	Hospital Universitari Vall d'Hebron Research Institute	N/A
Completed	Lanreotide in the Treatment of Small Bowel Motility Disorders NCT03012594	Northwell Health	Phase 2
Completed	Oropharyngeal Administration of Mother's Milk in Preterm Infants and Gastrointestinal Motility NCT03552510	Mansoura University Children Hospital	N/A
Terminated	Gastrointestinal Motility Among Diabetes Patients NCT02573519	University of Aarhus	N/A
Completed	The Effect of Prucalopride (Resolor®) on Gastric Motor Function and Gastric Sensitivity NCT04429802	Universitaire Ziekenhuizen KU Leuven	N/A
Completed	Nitric Oxide Control of Migrating Motor Complex: L-NMMA Effects in Relation to Receptor Blockades NCT02245165	Uppsala University	Phase 1
Terminated	A Phase 1, Multiple Intravenous Dose Study to Examine Safety, Tolerability, and PK of Intravenous TD-8954, a 5 NCT01644240	Theravance Biopharma	Phase 1
Completed	Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis NCT01394055	Motus Therapeutics, Inc.	Phase 1
Completed	Absorption of Paracetamol, Talinolol and Amoxicillin After Oral Administration Using Non-caloric and Caloric W NCT01635608	University Medicine Greifswald	Phase 1
Unknown	Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition A NCT00793195	The Hospital for Sick Children	Phase 2